Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.6 - $1.53 $1,933 - $4,931
-3,223 Reduced 10.46%
27,583 $16,000
Q2 2023

Aug 14, 2023

SELL
$1.05 - $1.63 $14,196 - $22,037
-13,520 Reduced 30.5%
30,806 $34,000
Q1 2023

May 15, 2023

SELL
$1.2 - $2.73 $58,417 - $132,899
-48,681 Reduced 52.34%
44,326 $59,000
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $5,229 - $11,039
3,058 Added 3.4%
93,007 $172,000
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $158,760 - $721,105
-83,558 Reduced 48.16%
89,949 $220,000
Q2 2022

Aug 22, 2022

BUY
$2.13 - $9.01 $4,958 - $20,975
2,328 Added 1.36%
173,507 $424,000
Q1 2022

May 16, 2022

BUY
$6.28 - $15.59 $9,934 - $24,663
1,582 Added 0.93%
171,179 $1.36 Million
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $67,855 - $132,340
4,616 Added 2.8%
169,597 $2.59 Million
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $883,522 - $1.22 Million
-36,344 Reduced 18.05%
164,981 $4.69 Million
Q2 2021

Aug 12, 2021

BUY
$26.09 - $40.4 $3.09 Million - $4.79 Million
118,603 Added 143.38%
201,325 $6.79 Million
Q1 2021

May 17, 2021

BUY
$33.06 - $56.93 $64,334 - $110,785
1,946 Added 2.41%
82,722 $3.16 Million
Q4 2020

Feb 12, 2021

SELL
$39.09 - $57.4 $395,043 - $580,084
-10,106 Reduced 11.12%
80,776 $3.38 Million
Q3 2020

Nov 13, 2020

SELL
$28.43 - $44.67 $88,587 - $139,191
-3,116 Reduced 3.31%
90,882 $3.94 Million
Q2 2020

Aug 14, 2020

BUY
$11.71 - $30.29 $368,876 - $954,165
31,501 Added 50.4%
93,998 $2.85 Million
Q1 2020

May 14, 2020

BUY
$7.64 - $27.5 $16,655 - $59,950
2,180 Added 3.61%
62,497 $873,000
Q4 2019

Feb 13, 2020

BUY
$15.02 - $20.57 $57,181 - $78,309
3,807 Added 6.74%
60,317 $973,000
Q3 2019

Nov 13, 2019

BUY
$18.85 - $27.5 $726,045 - $1.06 Million
38,517 Added 214.07%
56,510 $1.09 Million
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $72,797 - $110,097
4,191 Added 30.37%
17,993 $398,000
Q1 2019

May 15, 2019

BUY
$10.65 - $25.75 $30,916 - $74,752
2,903 Added 26.64%
13,802 $324,000
Q3 2018

Nov 20, 2018

BUY
$7.54 - $18.31 $10,405 - $25,267
1,380 Added 14.5%
10,899 $183,000
Q2 2018

Aug 10, 2018

BUY
$4.87 - $8.42 $10,538 - $18,220
2,164 Added 29.42%
9,519 $70,000
Q1 2018

May 17, 2018

SELL
$4.69 - $10.05 $17,076 - $36,592
-3,641 Reduced 33.11%
7,355 $34,000
Q4 2017

Feb 13, 2018

BUY
$7.86 - $9.99 $86,428 - $109,850
10,996
10,996 $102,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.